A Ph.D. holder in Public Health Epidemiology with research focus on infectious disease antibiotic resistance, focusing on Gram-negative and Gram-positive organisms among elderly patients all over the world.
To give back to his home country, he established TDMC in Lagos State, Nigeria, in 2025. He previously served as a Specialist Biomedical Scientist with the South Eastern Health & Social Care Trust (NHS), United Kingdom, for over 15 years. He later spent another five years working as a Biomedical Science consultant in the UK. He is a π ππ₯π₯π¨π° & ππ‘ππ«πππ«ππ πππ’ππ§ππ’π¬π of the Institute of Biomedical Science London. He is also a founder of TunMicro Sickle Cell Foundation (TSCF), a UK non-profit organization. Through TSCF, Dr I.O. Sule seeks to reduce the threat of sickle cell disease in sub-Sahara Africa by combining academic discourse with personal narratives through free Genotype/ Sickle cell testing for Nigerian children and adolescent youths.
As a CEO of this medical centre, he is responsible for making major corporate decisions, managing the overall operations and resources of TDMC, acting as the main point of communication between the board of directors (the board) and corporate